HomeTagsUK approves combination therapies of GSK's blood cancer drug Blenrep

UK approves combination therapies of GSK's blood cancer drug Blenrep
U

Continue reading...

UK approves combination therapies of GSK’s blood cancer drug Blenrep

UK approves combination therapies of GSK's blood cancer drug Blenrep GSK (GSK.L), opens new tab said on Thursday two combination therapies with its cancer drug, Blenrep, have...

Subscribe for Exclusive Access

All

Exclusive Content

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

October 25, 2024

All

Exclusive Content

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

October 25, 2024

The World of Health & Medicine News

Abu Dhabi’s M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases

UK approves combination therapies of GSK’s blood cancer drug Blenrep

US FDA limits industry employees from roles in its advisory committees

Sanofi-Regeneron’s Dupixent gets FDA’s nod for skin condition

EU authorizes Eisai-Biogen’s drug for early Alzheimer’s treatment

Menstrual blood is being used to research a range of health conditions — from endometriosis to diabetes and cancer

Lilly weight-loss pill works as well as Ozempic, shares surge

Same Symptoms, Different Care: How AI’s Hidden Bias Alters Medical Decisions

Tariff wars to hit popular US-made drugs in China, regulator data shows

WHO says member states reach agreement to tackle future pandemics

Or continue exploring...

UK approves combination therapies of GSK's blood cancer drug Blenrep
U

Continue reading...

UK approves combination therapies of GSK’s blood cancer drug Blenrep

Subscribe for Exclusive Access

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

The World of Health & Medicine News

Or continue exploring...

UK approves combination therapies of GSK's blood cancer drug BlenrepU

Continue reading...

Subscribe for Exclusive Access

.tdi_173{margin-bottom:40px!important} EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

.tdi_192{margin-bottom:40px!important} EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

.tdi_211{margin-bottom:40px!important} EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

UK approves combination therapies of GSK's blood cancer drug Blenrep
U

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources